about
Mosaic organization of DNA nucleotidesLong-range correlation properties of coding and noncoding DNA sequences: GenBank analysis.Long-range correlations in nucleotide sequencesInhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric propertiesThe neuropilin 1 cytoplasmic domain is required for VEGF-A-dependent arteriogenesisVasa vasorum in normal and diseased arteriesSyndecan-4 signaling at a glanceLymphatic fate specification: an ERK-controlled transcriptional programInter-cellular exchange of cellular components via VE-cadherin-dependent trans-endocytosisVEGF signaling inside vascular endothelial cells and beyond.Endothelial deletion of murine Jag1 leads to valve calcification and congenital heart defects associated with Alagille syndromeDelayed arteriogenesis in hypercholesterolemic miceCopper chelation represses the vascular response to injuryFRS2 via fibroblast growth factor receptor 1 is required for platelet-derived growth factor receptor beta-mediated regulation of vascular smooth muscle marker gene expressionSuppression of RhoG activity is mediated by a syndecan 4-synectin-RhoGDI1 complex and is reversed by PKCalpha in a Rac1 activation pathway.Phosphorylation of VE-cadherin controls endothelial phenotypes via p120-catenin coupling and Rac1 activation.Fractals in biology and medicine.Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization.Magnetic resonance imaging demonstrates improved regional systolic wall motion and thickening and myocardial perfusion of myocardial territories treated by laser myocardial revascularization.Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia.The impact of clinical data on interpretation of thallium scintigrams.Evolving revascularization approaches for myocardial ischemia.Arteriogenesis: noninvasive quantification with multi-detector row CT angiography and three-dimensional volume rendering in rodents.Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia.Chapter 14. Assessment of arteriogenesis.Abnormalities in the regulators of angiogenesis in patients with sclerodermaALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway.Diabetic monocyte and vascular endothelial growth factor signaling impairment.Angiogenesis in cardiovascular disease: current status and therapeutic potential.ERK1/2-Akt1 crosstalk regulates arteriogenesis in mice and zebrafish.Vascular adaptation to a dysfunctional endothelium as a consequence of Shb deficiency.Heterogeneity among RIP-Tag2 insulinomas allows vascular endothelial growth factor-A independent tumor expansion as revealed by studies in Shb mutant mice: implications for tumor angiogenesisDll4-Notch signaling determines the formation of native arterial collateral networks and arterial function in mouse ischemia models.Correlation approach to identify coding regions in DNA sequences.Fractal landscapes and molecular evolution: modeling the myosin heavy chain gene family.Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis.Gene transfer for angiogenesis in coronary artery disease.Endothelial Akt1 mediates angiogenesis by phosphorylating multiple angiogenic substrates.Chemokine-coupled β2 integrin-induced macrophage Rac2-Myosin IIA interaction regulates VEGF-A mRNA stability and arteriogenesis.Fibroblast growth factor signaling potentiates VE-cadherin stability at adherens junctions by regulating SHP2
P50
Q21563753-ED02BC32-0F3C-44E0-9873-701813AEEAC2Q22065729-7BEEB84A-1471-4A22-91E3-FD6710EB6965Q22122363-DBEBA229-9915-4B9A-9FC1-EBBA9526B0E8Q24338659-C4F37F38-F0B9-4F55-91EC-186181E57EFEQ24339531-6619109F-2E98-482C-A097-A0E730A832C5Q26830962-2CD27D9C-8343-487B-AA76-EEB6F3813BFBQ26865478-D348E2F2-4A84-41DD-8A99-78FC0C10114DQ27005981-DF9F9878-ACC4-454E-B2E8-8BE5CA02E6E2Q27317113-C81D4289-A8D9-4999-9016-A50B9A8A908EQ27687815-8988A70C-14CA-4331-AF57-522819490646Q28277874-908B80D6-C6D1-475A-AB43-D2D0BF85472FQ28511993-3ABDA01D-63B1-46E9-8546-6472170CA7D8Q28570754-211FE8E5-F5C0-4612-9D27-5E4E39494AA2Q28572993-5C3810B8-90B2-450A-85E7-8B45A3481A56Q30437384-6D6E2E9C-925F-46EB-8C44-741BA661A4F7Q30497938-15BEBBD4-B25B-4FFB-A5C8-FF46C92ED8EBQ30539702-E373F83A-B348-47E0-A4DA-CDCA089221A0Q30579125-DF72D535-B1D9-4A1D-9480-172565067760Q30783874-3367889A-F46F-4BF1-8A36-527A0ABD2FAAQ32055174-E82138D7-1955-49E1-8363-BC6E3701DAB0Q32156871-8B8C7950-B847-470C-BA95-BF12FA826A85Q33194984-5641CDCB-4CBD-4EB2-A781-8D72053C88D2Q33254867-729DC205-4226-4139-828E-1CF4F5FF3D0BQ33344368-48E775A7-5F9D-44DA-8004-3BA9633B4DE9Q33385875-91740AE9-A657-429D-991D-6FD3173C0A05Q33606645-37A9B901-2CC6-4817-B089-498101524556Q33719706-B38AE2AB-6330-4D41-A70E-3F529D71F782Q33725003-2295C22B-751D-4466-A424-7CB7896B60E5Q33736237-A9E31061-59FD-41A5-BCA8-EA351286D408Q33755332-4AE60AEE-210F-4187-951B-171B0E6E182DQ33762804-728A6D8E-3CC8-4DD2-9526-E69C53E7F4A2Q33804203-ABABD23F-DE99-451E-B80A-1B7C081BCD88Q33818037-3D1145FB-9197-4E23-846F-A3B9E50D7F13Q34018136-CF82B607-4FE0-4416-9D75-0D1294C9EE88Q34020294-D56F71DD-75DD-48B6-BADE-604A7D3DB3CBQ34081690-23FE4B17-A71D-4231-B72B-F5B4476AA41EQ34132035-25B9E1D7-565B-4E5B-8A3E-DE0DA6270249Q34144300-8AD591F3-2D41-4AB9-A8FE-4FD26E3F0FE6Q34230528-473CEFEA-A27E-45A3-B0DF-EDC8E265F401Q34282040-B40F2B29-7AB2-4AF4-8873-91BDB0B7CF55
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Michael Simons
@ast
Michael Simons
@en
Michael Simons
@es
Michael Simons
@nl
Michael Simons
@sl
type
label
Michael Simons
@ast
Michael Simons
@en
Michael Simons
@es
Michael Simons
@nl
Michael Simons
@sl
prefLabel
Michael Simons
@ast
Michael Simons
@en
Michael Simons
@es
Michael Simons
@nl
Michael Simons
@sl
P108
P244
P1053
G-8553-2014
P106
P1153
7201538867
P21
P214
12147266885635482486
P244
n2016187304
P31
P3829
P496
0000-0003-0348-7734
P734
P735
P7859
lccn-n2016187304